Global Vocal Biomarkers Market, By Therapeutic Applications(Psychiatric Disorders, Respiratory Disorders, Cardiovascular Disorders), End User(Hospitals, Health Insurers, Academic Institutes, Government Organizations), and Geography - Trends, Analysis and Forecast till 2028
- Report code : CMI3101 |
- Industry :
Healthcare IT
- Published On : Jan 2017 |
- Pages : 119 Pages |
- Format :
Vocal Biomarkers – Listening in to Your Body
Sound vibrations are used as part of therapeutic healing for various mental health conditions such as depression and anxiety. Recent research studies, however, have greatly broadened its application into diagnosis of diseases. Biomarkers in the voice of a person have been linked to disorders such as depression, coronary artery disease, and anxiety. On successful completion of clinical trials, HIPAA compliant vocal biomarker system would serve as much more effective alternative to current diagnostic techniques such as MRI, X-Ray, and CT scan. Research is also underway for identifying vocal biomarkers in diagnosis of Parkinson’s disease, traumatic brain injury, cognitive impairment, and respiratory disorders, which would open up a highly lucrative avenue for growth for players in this industry. Companies dealing with voice technology are sampling data to provide accurate results. For instance, Beyond Verbal, Inc. has been researching on vocal biomarkers since 1996, and has collected over 2.5 million voice samples in over 40 different languages.
While currently in its very nascent stage with an estimated value of US$ 6.4 million in 2017, the global vocal biomarkers market is expected to expand at a CAGR of 65.7% during the forecast period (2017 – 2028).
Figure 1. Global Vocal Biomarkers Market Size and Forecast, US$ Million and Y-o-Y Growth (%), 2017–2028
Source: Coherent Market Insights Analysis (2017)
To have a snippet of the report, request Report Sample
Growing Psychological and Cardiovascular Disease Prevalence: A Highly Conducive Growth Environment
Around 350 million people across the globe suffered from depression (WHO, 2016) and approximately 10 million people suffered from Parkinson’s disease globally (Parkinson’s disease Foundation, 2016). Over 235 million people suffered from asthma globally (2016), according to the European Respiratory Society. Diagnosis of these diseases is expensive and thus, is out of reach for most people in emerging economies. This results in high mortality rates in these regions. Vocal biomarker technology systems would act as an ideal cost-effective primary diagnostic tool that could help discern if the patient needs to further opt for expensive X-Ray/MRI/CT/EEG/ECG scans. Thus, millions of suffering from these chronic ailments explicates large potential for vocal biomarkers technology in the commercial space in the long run. Moreover, alterative conventionally used diagnostic systems need to adhere to stringent regulations pertaining to radiation. On the other hand, voice-based systems are based on technology that does not subject the user to any form of radiation and thus, is expected to gain significant traction in the near future.
Rising Demand for Minimally Invasive Techniques to Support the Progress of Vocal Biomarkers Market
Though MRI, CT, X-Ray and ECG, are minimally invasive technologies, they are out of reach for remotely located population. Also, patients prefer minimally invasive procedures as these allow for speedy recovery post procedure. Moreover, high costs of these tests results in substantial healthcare burden for governments and insurance companies alike. Vocal biomarkers is a non-invasive technology and provides great simplicity to an individual. This is therefore analyzed to provide a competitive edge over existing diagnostic technologies that lack the capability to carry preventive diagnosis. Furthermore, this extremely user-friendly system falls perfectly in line with increasing self-diagnosis and self-medication trend, which would significantly fuel demand for vocal biomarkers.
Strategic Collaborations to Decrease the Turnaround Time for Commercialization of Products
Mr. Charles Marmar (Chairman, Department of Psychiatry, New York University's Langone Medical Center), is conducting a five year study to identify vocal biomarkers for diagnosis of traumatic brain injury (TBI), post-traumatic stress disorder (PTSB), and depression. Initial studies have identified 30 vocal characteristics that seem to be associated with TBI and PTSB. Mr. Marmar has collaborated with SRI International (a non-profit research institute based in California), to identify vocal biomarkers. Beyond Verbal, Inc. is working with Mayo Clinic, Haddassah Medical Center in Jerusalem, Scripps, and Tel Aviv University to expand its vocal biomarker’s research into healthcare sector.
A person’s voice can serve as an extremely useful tool in identifying the temperament and presence or risk of any disorders such as depression, Parkinson’s disease, and coronary artery disease. Factoring this, scientists from research institutes and companies (dealing with voice and speech technology) are partnering to identify vocal biomarkers that can aid in accurate diagnosis of diseases. Vocal biomarkers technology could be a disruptive innovation in the field of medical diagnostics, allowing for minimally-invasive diagnostic procedures to detect serious conditions. Beyond Verbal, Inc. Cogito Corporation, and Sonde Health are developing a voice-based platform to diagnose mental and physical health of a person. The projected success of the market mainly hinges upon the R&D conducted by these major companies.
Market Dynamics
Still in the clinical stage, the global vocal biomarkers technology would transform the way we mental and physical health is diagnosed and would transform the healthcare industry. This voice-based technology would allow for early diagnosis of diseases and accordingly help in taking preventive measures. This can significantly benefit military, hospitals and health clinics, and also individuals to monitor health and take appropriate medical action.
Collaborative efforts across different ecosystem players are bringing positive traction in global vocal biomarkers market. Sonde Health obtained technology license from the Massachusetts Institute of Technology Lincoln Laboratory for the latter’s voice-based technology platform intended for monitoring and diagnosis of various mental and physical conditions. Beyond Verbal, Inc. collaborated with Mayo Clinic in 2016 to conduct studies and identify the vocal biomarkers that could help in diagnosing mental and physical health.
Market Taxonomy
This report segments the vocal biomarkers market on the basis of application and end users. On the basis of application the vocal biomarkers market is segmented into psychological disorders, respiratory disorders and cardiovascular disorders. End users of this technology as covered in the report are hospitals, academic & research institutes, health insurers, and military. The market potential for vocal biomarkers has been analyzed across major geographies, namely North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Key features of the study:
- This report provides in-depth analysis of the vocal biomarkers and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR) (%) for the forecast period (2017 – 2028),
- It elucidates potential revenue opportunity across different segments and details attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
- It profiles leading players in the global vocal biomarkers market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
- Key companies covered as a part of this study include Beyond Verbal, Inc., Cogito Corporation, Sonde Health, Sharecare, Inc., and IBM Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology upgrade, market expansion and marketing tactics
- The global vocal biomarkers market report caters to various stakeholders in this industry including investors, device manufacturers, system manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the vocal biomarkers market
Detailed Segmentation:
- Global Vocal Biomarkers Market, By Therapeutic Applications:
- Psychiatric Disorders
- Depression and Anxiety Disorders
- Parkinson’s Disease
- Cognitive Impairment
- Other Mental Illness
- Respiratory Disorders
- Cardiovascular Disorders
- Psychiatric Disorders
- Global Vocal Biomarkers Market, By End User:
- Hospitals
- Health Insurers
- Academic Institutes
- Government Organizations
- Global Vocal Biomarkers Market, By Geography:
- North America
- By Therapeutic Applications:
- Psychiatric Disorders
- Depression and Anxiety Disorders
- Parkinson’s Disease
- Cognitive Impairment
- Other Mental Illness
- Respiratory Disorders
- Cardiovascular Disorders
- Psychiatric Disorders
- By End User:
- Hospitals
- Health Insurers
- Academic Institutes
- Government Organizations
- By Therapeutic Applications:
- Europe
- By Therapeutic Applications:
- Psychiatric Disorders
- Depression and Anxiety Disorders
- Parkinson’s Disease
- Cognitive Impairment
- Other Mental Illness
- Respiratory Disorders
- Cardiovascular Disorders
- Psychiatric Disorders
- By End User:
- Hospitals
- Health Insurers
- Academic Institutes
- Government Organizations
- By Therapeutic Applications:
- Asia-Pacific
- By Therapeutic Applications:
- Psychiatric Disorders
- Depression and Anxiety Disorders
- Parkinson’s Disease
- Cognitive Impairment
- Other Mental Illness
- Respiratory Disorders
- Cardiovascular Disorders
- Psychiatric Disorders
- By End User:
- Hospitals
- Health Insurers
- Academic Institutes
- Government Organizations
- By Therapeutic Applications:
- Latin America
- By Therapeutic Applications:
- Psychiatric Disorders
- Depression and Anxiety Disorders
- Parkinson’s Disease
- Cognitive Impairment
- Other Mental Illness
- Respiratory Disorders
- Cardiovascular Disorders
- Psychiatric Disorders
- By End User:
- Hospitals
- Health Insurers
- Academic Institutes
- Government Organizations
- Middle East and Africa
- By Therapeutic Applications:
- Psychiatric Disorders
- Depression and Anxiety Disorders
- Parkinson’s Disease
- Cognitive Impairment
- Other Mental Illness
- Respiratory Disorders
- Cardiovascular Disorders
- Psychiatric Disorders
- By End User:
- Hospitals
- Health Insurers
- Academic Institutes
- Government Organizations
- By Therapeutic Applications:
- North America
- Company Profiles
- Beyond verbal, Inc.*
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments
- Future Plans
- Cogito Corporation
- Sonde Health
- IBM Corporation
- Sharecare, Inc.
- Beyond verbal, Inc.*
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
- Research Objective and assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet By Therapeutic Application
- Market Snippet By End User
- Market Snippet By Region
- Coherent Opportunity Map (COM)
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Regulatory Scenario
- Epidemiology/Prevalence/Incidence
- Mergers and Acquisitions
- New Product Approvals/Launch
- Global Vocal Biomarkers Market, By Therapeutic Application, 2016 - 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2017 and 2028 (%)
- Y-O-Y Growth Analysis, 2016 - 2028
- Segment Trends
- Psychological Disorders
- Introduction
- Market Share Analysis, 2017 and 2028 (%)
- Y-O-Y Growth Analysis, 2016 – 2028
- Depression and Anxiety
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2016 - 2028, (US$ Million)
- Parkinson’s Disease
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2016 - 2028, (US$ Million)
- Cognitive Impairment
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2016 - 2028, (US$ Million)
- Other Mental Illnesses
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2016 - 2028, (US$ Million)
- Respiratory Disorders
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2016 - 2028, (US$ Million)
- Cardiovascular Disorders
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2016 - 2028, (US$ Million)
- Global Vocal Biomarkers Market, By End User, 2016 - 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2017 and 2028 (%)
- Y-O-Y Growth Analysis, 2016 - 2028
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2016 - 2028, (US$ Million)
- Health Insurers
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2016 - 2028, (US$ Million)
- Academic & Research Institutions
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2016 - 2028, (US$ Million)
- Government Organizations
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2016 - 2028, (US$ Million)
- Global Vocal Biomarkers Market, By Regions, 2016 - 2028 (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2017 and 2028 (%)
- Y-O-Y Growth Analysis, By Regions, 2016 - 2028
- North America
- Market Share Analysis, By Segments, 2017 and 2028 (%)
- Y-O-Y Growth Analysis, By Segments, 2016 - 2028
- North America Vocal Biomarkers Market, By Therapeutic Application
- Market Size and Forecast, 2016 - 2028 (US$ Million)
- North America Vocal Biomarkers Market, By End User
- Market Size and Forecast, 2016 - 2028 (US$ Million)
- Europe
- Market Share Analysis, By Segments, 2017 and 2028 (%)
- Y-O-Y Growth Analysis, By Segments, 2016 - 2028
- Europe Vocal Biomarkers Market, By Therapeutic Application
- Market Size and Forecast, 2016 - 2028 (US$ Million)
- Europe Vocal Biomarkers Market, By End User
- Market Size and Forecast, 2016 - 2028 (US$ Million)
- Asia Pacific
- Market Share Analysis, By Segments, 2017 and 2028 (%)
- Y-O-Y Growth Analysis, By Segments, 2016 - 2028
- Asia Pacific Vocal Biomarkers Market, By Therapeutic Application
- Market Size and Forecast, 2016 - 2028 (US$ Million)
- Asia Pacific Vocal Biomarkers Market, By End User
- Market Size and Forecast, 2016 - 2028 (US$ Million)
- Latin America
- Market Share Analysis, By Segments, 2017 and 2028 (%)
- Y-O-Y Growth Analysis, By Segments, 2016 - 2028
- Latin America Vocal Biomarkers Market, By Therapeutic Application
- Market Size and Forecast, 2016 - 2028 (US$ Million)
- Latin America Vocal Biomarkers Market, By End User
- Market Size and Forecast, 2016 - 2028 (US$ Million)
- Middle East & Africa (MEA)
- Market Share Analysis, By Segments, 2017 and 2028 (%)
- Y-O-Y Growth Analysis, By Segments, 2016 - 2028
- MEA Vocal Biomarkers Market, By Therapeutic Application
- Market Size and Forecast, 2016 - 2028 (US$ Million)
- MEA Vocal Biomarkers Market, By End User
- Market Size and Forecast, 2016 - 2028 (US$ Million)
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Beyond Verbal, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Sonde Health
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Sharecare, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- IBM Coporation
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Cogito Corporation
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Analyst Views
- Section
- References
- Research Methodology
- About us and Sales Contact
*Browse 70 market data tables and 25 figures on "Vocal Biomarkers Market - Global forecast to 2028”.
Related Insights :
Share
Choose License Type
"How Can I Help You" ?
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Key Benefits
Custom Research Solution
Talk to our research consultant to design an exclusive report as per your research needs.
Customer Fulfilment
We aim to fulfil client's research demands with tailored research solutions.
Quick Turnaround Time Reports
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
360-degree Approach
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
Assured Quality
We strive to provide most accurate and reliable research findings in our research reports.